These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

968 related items for PubMed ID: 17415690

  • 1. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.
    Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
    [Abstract] [Full Text] [Related]

  • 2. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
    Barnebey HS, Orengo-Nania S, Flowers BE, Samples J, Mallick S, Landry TA, Bergamini MV.
    Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
    [Abstract] [Full Text] [Related]

  • 3. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [Abstract] [Full Text] [Related]

  • 4. A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension.
    Hughes BA, Bacharach J, Craven ER, Kaback MB, Mallick S, Landry TA, Bergamini MV.
    J Glaucoma; 2005 Oct; 14(5):392-9. PubMed ID: 16148589
    [Abstract] [Full Text] [Related]

  • 5. Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
    Fellman RL, Sullivan EK, Ratliff M, Silver LH, Whitson JT, Turner FD, Weiner AL, Davis AA, Travoprost Study Group.
    Ophthalmology; 2002 May; 109(5):998-1008. PubMed ID: 11986110
    [Abstract] [Full Text] [Related]

  • 6. A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.
    Denis P, Andrew R, Wells D, Friren B.
    Eur J Ophthalmol; 2006 May; 16(3):407-15. PubMed ID: 16761242
    [Abstract] [Full Text] [Related]

  • 7. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E, Carrasco FG, Costa VP, Casiraghi JF, Vargas E, Sarmina JS, Mayol R.
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [Abstract] [Full Text] [Related]

  • 8. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.
    Goldberg I, Cunha-Vaz J, Jakobsen JE, Nordmann JP, Trost E, Sullivan EK, International Travoprost Study Group.
    J Glaucoma; 2001 Oct; 10(5):414-22. PubMed ID: 11711841
    [Abstract] [Full Text] [Related]

  • 9. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA, Travoprost Study Group.
    Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
    [Abstract] [Full Text] [Related]

  • 10. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
    Parrish RK, Palmberg P, Sheu WP, XLT Study Group.
    Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
    [Abstract] [Full Text] [Related]

  • 11. Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.
    Sarkisian SR, Ang RE, Lee AM, Berdahl JP, Heersink SB, Burden JH, Doan LV, Stephens KG, Kothe AC, Usner DW, Katz LJ, Navratil T, GC-010 Travoprost Intraocular Implant Investigators.
    Ophthalmology; 2024 Sep; 131(9):1021-1032. PubMed ID: 38423216
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
    Centofanti M, Oddone F, Gandolfi S, Hommer A, Boehm A, Tanga L, Sangermani C, Sportelli V, Haustein M, Manni G, Rossetti L.
    Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC, Konstas AG, Nelson LA, Kruft B.
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [Abstract] [Full Text] [Related]

  • 14. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ, Olander KW, Kim EE, Grunden JW, Kwok KK, Tressler CS, United States Fixed-Combination Study Group.
    Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
    Schuman JS, Katz GJ, Lewis RA, Henry JC, Mallick S, Wells DT, Sullivan EK, Landry TA, Bergamini MV, Robertson SM.
    Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
    [Abstract] [Full Text] [Related]

  • 16. Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety.
    Martinez-de-la-Casa JM, Castillo A, Garcia-Feijoo J, Mendez-Hernandez C, Fernandez-Vidal A, Garcia-Sanchez J.
    Curr Med Res Opin; 2004 Sep; 20(9):1333-9. PubMed ID: 15383180
    [Abstract] [Full Text] [Related]

  • 17. MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension.
    Stalmans I, Lim KS, Oddone F, Fichtl M, Belda JI, Hommer A, Laganovska G, Schweitzer C, Voykov B, Zarnowski T, Holló G.
    Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):179-190. PubMed ID: 37615697
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A, Paczka JA, Jiménez-Román J, Hartleben C.
    BMC Ophthalmol; 2014 Dec 19; 14():161. PubMed ID: 25527295
    [Abstract] [Full Text] [Related]

  • 19. Observational study of patients switched to the fixed travoprost 0.004%/timolol 0.5% combination in Croatia.
    Mandic Z, Novak-Lauš K, Bojic L, Popovic-Suic S, Maricic-Došen V, Pelcic G, Dobutovic D, Biuk D, Kovacic Z, Pavan J.
    Methods Find Exp Clin Pharmacol; 2010 Oct 19; 32(8):593-8. PubMed ID: 21132129
    [Abstract] [Full Text] [Related]

  • 20. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM, Bimatoprost Circadian IOP Study Group.
    Surv Ophthalmol; 2004 Mar 19; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.